company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 18:31:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1233000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 18:31:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1233000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 18:31:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1233000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 18:31:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5068000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 18:31:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20239000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 18:31:04+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 18:31:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25307000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 18:31:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-24074000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 18:31:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,729000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 18:31:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,253000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 18:31:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-643000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 18:31:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1119000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 18:31:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-25193000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 18:31:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25193000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 18:31:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25193000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 18:31:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-25193000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 18:31:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,359900000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 18:31:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 18:31:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,359900000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 18:31:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 18:31:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,337404000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 18:31:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 16:15:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,781000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 16:15:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,781000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 16:15:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,781000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 16:15:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4948000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 16:15:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18941000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 16:15:42+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1145000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 16:15:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25034000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 16:15:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-24253000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 16:15:42+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,637000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 16:15:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,51000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 16:15:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2700000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 16:15:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3286000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 16:15:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-27539000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 16:15:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-26000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 16:15:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27513000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 16:15:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27513000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 16:15:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27513000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 16:15:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,343900000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 16:15:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 16:15:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,343900000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 16:15:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 16:15:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,337404000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2010.0,Q3,2010-07-01,2010-09-30,2011-11-01 16:15:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,596000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,596000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,596000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4753000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23921000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:50+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1058000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29732000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-29136000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,607000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,87000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:50+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,29656000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,29136000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,0.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,337527000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,337527000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,337527000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q1,2011-01-01,2011-03-31,2012-05-03 16:06:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:09:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,555000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:09:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,555000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:09:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,555000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:09:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4532000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:09:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20145000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:09:10+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1804000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:09:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26481000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:09:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25926000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:09:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,810000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:09:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,68000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:09:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,26668000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:09:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,25926000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:09:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,0.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:09:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:09:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,337668000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:09:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:09:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,337668000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:09:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:09:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,337668000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:09:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q3,2011-07-01,2011-09-30,2011-11-01 16:15:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,355000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q3,2011-07-01,2011-09-30,2011-11-01 16:15:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,355000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q3,2011-07-01,2011-09-30,2011-11-01 16:15:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,355000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q3,2011-07-01,2011-09-30,2011-11-01 16:15:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4055000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q3,2011-07-01,2011-09-30,2011-11-01 16:15:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19655000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q3,2011-07-01,2011-09-30,2011-11-01 16:15:42+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2336000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q3,2011-07-01,2011-09-30,2011-11-01 16:15:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26046000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q3,2011-07-01,2011-09-30,2011-11-01 16:15:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25691000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q3,2011-07-01,2011-09-30,2011-11-01 16:15:42+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,560000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q3,2011-07-01,2011-09-30,2011-11-01 16:15:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,60000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q3,2011-07-01,2011-09-30,2011-11-01 16:15:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,88000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q3,2011-07-01,2011-09-30,2011-11-01 16:15:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-412000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q3,2011-07-01,2011-09-30,2011-11-01 16:15:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-26103000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q3,2011-07-01,2011-09-30,2011-11-01 16:15:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q3,2011-07-01,2011-09-30,2011-11-01 16:15:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26103000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q3,2011-07-01,2011-09-30,2011-11-01 16:15:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26103000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q3,2011-07-01,2011-09-30,2011-11-01 16:15:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-26103000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q3,2011-07-01,2011-09-30,2011-11-01 16:15:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,326300000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q3,2011-07-01,2011-09-30,2011-11-01 16:15:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q3,2011-07-01,2011-09-30,2011-11-01 16:15:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,326300000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q3,2011-07-01,2011-09-30,2011-11-01 16:15:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q3,2011-07-01,2011-09-30,2011-11-01 16:15:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,337678000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q3,2011-07-01,2011-09-30,2011-11-01 16:15:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,343000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,343000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,343000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4010000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28107000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1568000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33685000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-33342000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,551000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,40000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-56259000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-56770000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-90112000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-90112000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-90112000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-90112000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,341800000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,341800000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,340761000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 16:06:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,300000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 16:06:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,300000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 16:06:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,300000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 16:06:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4565000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 16:06:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23037000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 16:06:50+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2081000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 16:06:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29683000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 16:06:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-29383000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 16:06:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,537000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 16:06:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,56000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 16:06:50+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,29864000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 16:06:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,29383000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 16:06:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,0.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 16:06:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 16:06:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,480324000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 16:06:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 16:06:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,480324000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 16:06:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 16:06:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,480324000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q1,2012-01-01,2012-03-31,2012-05-03 16:06:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:43:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,199000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:43:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,199000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:43:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,199000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:43:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4162000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:43:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19355000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:43:45+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2162000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:43:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25679000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:43:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25480000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:43:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,530000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:43:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,58000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:43:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,25952000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:43:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,25480000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:43:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,0.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:43:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:43:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,480634000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:43:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:43:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,480634000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:43:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:43:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,480634000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q2,2012-04-01,2012-06-30,2013-08-01 16:43:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:16:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,372000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:16:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,372000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:16:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,372000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:16:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4396000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:16:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19192000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:16:44+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,5844000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:16:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29432000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:16:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-29060000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:16:44+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,527000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:16:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,44000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:16:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:16:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-479000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:16:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-29539000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:16:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29539000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:16:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29539000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:16:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-29539000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:16:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,492300000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:16:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:16:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,492300000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:16:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:16:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,490049000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 08:16:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,218000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,218000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,218000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3920000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20990000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-200000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24710000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-24492000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,520000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,55000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-55715000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-56180000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-80672000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-80672000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-80672000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-80672000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,479200000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,479200000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,489707000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 08:59:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,360000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 08:59:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,360000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 08:59:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,360000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 08:59:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4324000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 08:59:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20327000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 08:59:56+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1264000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 08:59:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25915000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 08:59:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25555000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 08:59:56+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,506000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 08:59:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,53000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 08:59:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,26008000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 08:59:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,25555000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 08:59:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,0.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 08:59:56+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 08:59:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,512428000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 08:59:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 08:59:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,512428000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 08:59:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 08:59:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,512428000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 08:59:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:23:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,214000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:23:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,214000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:23:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,214000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:23:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4669000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:23:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23692000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:23:15+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,477000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:23:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28838000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:23:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28624000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:23:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,496000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:23:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,44000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:23:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:23:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-456000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:23:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-29080000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:23:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29080000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:23:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29080000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:23:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-29080000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:23:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,484700000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:23:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:23:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,484700000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:23:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:23:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,513083000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 16:23:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:18:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,238000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:18:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,238000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:18:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,238000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:18:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4716000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:18:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25400000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:18:27+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1338000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:18:27+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:18:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31454000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:18:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-31216000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:18:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,492000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:18:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,39000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:18:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:18:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-442000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:18:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-31658000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:18:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31658000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:18:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31658000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:18:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-31658000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:18:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,527600000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:18:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:18:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,527600000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:18:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:18:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,513419000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 16:18:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1410000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1410000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1410000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3412000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20263000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-5289000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18386000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16976000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,477000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-136000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-25799000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-26412000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-43388000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-43388000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-43388000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-43388000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73300000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.59
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73300000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.59
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73302000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.59
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:49:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,277000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:49:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,277000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:49:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,277000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:49:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5654000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:49:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23953000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:49:23+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1142000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:49:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,30749000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:49:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-30472000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:49:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,457000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:49:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,94000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:49:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-363000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:49:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-30835000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:49:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30835000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:49:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30835000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:49:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30835000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:49:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,513900000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:49:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:49:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,513900000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:49:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:49:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,513955000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q1,2014-01-01,2014-03-31,2015-05-05 16:49:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:11:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,676000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:11:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,676000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:11:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,676000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:11:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5152000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:11:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21187000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:11:51+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,448000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:11:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26787000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:11:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26111000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:11:51+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,455000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:11:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,538000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:11:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,83000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:11:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-26028000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:11:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26028000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:11:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26028000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:11:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-26028000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:11:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74400000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:11:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:11:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74400000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:11:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:11:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73518000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 16:11:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q3,2014-07-01,2014-09-30,2014-11-06 16:18:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,419000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q3,2014-07-01,2014-09-30,2014-11-06 16:18:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,419000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q3,2014-07-01,2014-09-30,2014-11-06 16:18:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,419000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q3,2014-07-01,2014-09-30,2014-11-06 16:18:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4617000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q3,2014-07-01,2014-09-30,2014-11-06 16:18:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24108000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q3,2014-07-01,2014-09-30,2014-11-06 16:18:27+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-1072000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q3,2014-07-01,2014-09-30,2014-11-06 16:18:27+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,13102000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q3,2014-07-01,2014-09-30,2014-11-06 16:18:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,40755000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q3,2014-07-01,2014-09-30,2014-11-06 16:18:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-40336000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q3,2014-07-01,2014-09-30,2014-11-06 16:18:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,449000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q3,2014-07-01,2014-09-30,2014-11-06 16:18:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q3,2014-07-01,2014-09-30,2014-11-06 16:18:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,282000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q3,2014-07-01,2014-09-30,2014-11-06 16:18:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-162000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q3,2014-07-01,2014-09-30,2014-11-06 16:18:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-40498000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q3,2014-07-01,2014-09-30,2014-11-06 16:18:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-40498000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q3,2014-07-01,2014-09-30,2014-11-06 16:18:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-40498000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q3,2014-07-01,2014-09-30,2014-11-06 16:18:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-40498000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q3,2014-07-01,2014-09-30,2014-11-06 16:18:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,506200000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q3,2014-07-01,2014-09-30,2014-11-06 16:18:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q3,2014-07-01,2014-09-30,2014-11-06 16:18:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,506200000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q3,2014-07-01,2014-09-30,2014-11-06 16:18:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q3,2014-07-01,2014-09-30,2014-11-06 16:18:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,514796000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q3,2014-07-01,2014-09-30,2014-11-06 16:18:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21482000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21482000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21482000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3988000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20031000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,910000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24929000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3447000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,892000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-5000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1341000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,444000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3003000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-70000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2933000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2933000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2933000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,76600000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,76600000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,76347000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q1,2015-01-01,2015-03-31,2015-05-05 16:49:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1792000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q1,2015-01-01,2015-03-31,2015-05-05 16:49:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1792000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q1,2015-01-01,2015-03-31,2015-05-05 16:49:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1792000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q1,2015-01-01,2015-03-31,2015-05-05 16:49:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5701000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q1,2015-01-01,2015-03-31,2015-05-05 16:49:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20865000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q1,2015-01-01,2015-03-31,2015-05-05 16:49:23+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1753000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q1,2015-01-01,2015-03-31,2015-05-05 16:49:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28319000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q1,2015-01-01,2015-03-31,2015-05-05 16:49:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26527000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q1,2015-01-01,2015-03-31,2015-05-05 16:49:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1702000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q1,2015-01-01,2015-03-31,2015-05-05 16:49:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,153000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q1,2015-01-01,2015-03-31,2015-05-05 16:49:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1549000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q1,2015-01-01,2015-03-31,2015-05-05 16:49:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28076000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q1,2015-01-01,2015-03-31,2015-05-05 16:49:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28076000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q1,2015-01-01,2015-03-31,2015-05-05 16:49:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28076000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q1,2015-01-01,2015-03-31,2015-05-05 16:49:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-28076000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q1,2015-01-01,2015-03-31,2015-05-05 16:49:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,701900000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q1,2015-01-01,2015-03-31,2015-05-05 16:49:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q1,2015-01-01,2015-03-31,2015-05-05 16:49:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,701900000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q1,2015-01-01,2015-03-31,2015-05-05 16:49:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q1,2015-01-01,2015-03-31,2015-05-05 16:49:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,724613000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q1,2015-01-01,2015-03-31,2015-05-05 16:49:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:11:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,376000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:11:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,376000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:11:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,376000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:11:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6307000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:11:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20769000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:11:51+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-12000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:11:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27064000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:11:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26688000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:11:51+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1655000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:11:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,269000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:11:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1386000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:11:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28074000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:11:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28074000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:11:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28074000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:11:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-28074000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:11:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,104000000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:11:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.27
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:11:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,104000000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:11:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.27
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:11:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,103608000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q2,2015-04-01,2015-06-30,2015-08-07 16:11:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.27
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:20:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,566000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:20:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,566000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:20:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,566000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:20:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5379000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:20:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23111000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:20:07+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,3404000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:20:07+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,2349000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:20:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34243000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:20:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-33677000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:20:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1687000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:20:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1687000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:20:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-35364000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:20:07+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,82000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:20:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-35282000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:20:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-35282000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:20:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-35282000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:20:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,103800000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:20:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.34
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:20:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,103800000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:20:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.34
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:20:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,103616000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 16:20:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.34
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,127280000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,127280000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,127280000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6448000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30442000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,782000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,1248000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38920000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,88360000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1678000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,150000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1528000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,86832000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-82000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,86750000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,86750000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,86750000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,93600000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.93
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,93600000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.93
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,103591000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.93
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12494000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12494000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12494000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8398000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,37002000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:05+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,965000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,46365000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-33871000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:05+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1649000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,637000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1012000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-34883000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34883000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34883000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-34883000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,102600000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.34
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,102600000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.34
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,103682000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.34
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:13:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20089000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:13:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20089000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:13:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:13:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20089000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:13:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8416000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:13:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,48216000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:13:53+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,478000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:13:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,57110000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:13:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-37021000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:13:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1638000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:13:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,547000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:13:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1091000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:13:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-38112000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:13:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:13:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-38112000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:13:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-38112000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:13:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-38112000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:13:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,103000000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:13:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.37
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:13:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,103000000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:13:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.37
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:13:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,103830000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q2,2016-04-01,2016-06-30,2017-08-01 16:13:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.37
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q3,2016-07-01,2016-09-30,2016-11-07 16:20:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,27717000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q3,2016-07-01,2016-09-30,2016-11-07 16:20:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,27717000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q3,2016-07-01,2016-09-30,2016-11-07 16:20:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27717000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q3,2016-07-01,2016-09-30,2016-11-07 16:20:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12263000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q3,2016-07-01,2016-09-30,2016-11-07 16:20:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52533000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q3,2016-07-01,2016-09-30,2016-11-07 16:20:07+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-2146000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q3,2016-07-01,2016-09-30,2016-11-07 16:20:07+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q3,2016-07-01,2016-09-30,2016-11-07 16:20:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,62650000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q3,2016-07-01,2016-09-30,2016-11-07 16:20:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-34933000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q3,2016-07-01,2016-09-30,2016-11-07 16:20:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1646000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q3,2016-07-01,2016-09-30,2016-11-07 16:20:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1646000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q3,2016-07-01,2016-09-30,2016-11-07 16:20:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-36579000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q3,2016-07-01,2016-09-30,2016-11-07 16:20:07+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,564000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q3,2016-07-01,2016-09-30,2016-11-07 16:20:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36015000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q3,2016-07-01,2016-09-30,2016-11-07 16:20:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36015000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q3,2016-07-01,2016-09-30,2016-11-07 16:20:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-36015000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q3,2016-07-01,2016-09-30,2016-11-07 16:20:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,102900000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q3,2016-07-01,2016-09-30,2016-11-07 16:20:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q3,2016-07-01,2016-09-30,2016-11-07 16:20:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,102900000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q3,2016-07-01,2016-09-30,2016-11-07 16:20:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q3,2016-07-01,2016-09-30,2016-11-07 16:20:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,103885000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q3,2016-07-01,2016-09-30,2016-11-07 16:20:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23037000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23037000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23037000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13967000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,40400000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,54367000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-31330000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1634000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1109000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-525000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-31855000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-564000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32419000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32419000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-32419000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,104000000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.31
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,104000000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.31
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,103863000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.31
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:07:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18293000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:07:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18293000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:07:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,225000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:07:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,225000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:07:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18068000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:07:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14871000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:07:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,43581000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:07:05+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2101000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:07:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,60553000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:07:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-42485000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:07:05+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1588000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:07:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,530000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:07:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1058000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:07:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-43543000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:07:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-8652000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:07:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34891000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:07:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34891000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:07:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-34891000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:07:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,105700000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:07:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.33
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:07:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,105700000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:07:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.33
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:07:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,104461000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q1,2017-01-01,2017-03-31,2017-05-04 16:07:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.33
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 16:31:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12053000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 16:31:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12053000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 16:31:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,537000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 16:31:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,537000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 16:31:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11516000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 16:31:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,18475000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 16:31:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26934000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 16:31:32+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 16:31:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,45409000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 16:31:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-33893000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 16:31:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1614000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 16:31:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,448000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 16:31:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1166000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 16:31:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-35059000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 16:31:32+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 16:31:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-35059000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 16:31:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-35059000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 16:31:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-35059000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 16:31:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,106200000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 16:31:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.33
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 16:31:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,106200000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 16:31:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.33
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 16:31:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,105300000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q2,2017-04-01,2017-06-30,2018-07-30 16:31:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.33
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:17:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26942000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:17:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26942000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:17:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,599000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:17:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,599000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:17:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26343000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:17:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16724000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:17:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,39137000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:17:13+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:17:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,55861000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:17:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-29518000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:17:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1619000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:17:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,415000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:17:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1204000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:17:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-30722000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:17:13+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:17:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30722000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:17:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30722000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:17:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30722000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:17:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,105900000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:17:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.29
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:17:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,105900000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:17:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.29
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:17:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,105582000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 17:17:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.29
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,34401000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,34401000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,538000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,538000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,33863000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16020000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,42571000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,58591000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-24728000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2163000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,561000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1602000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-26330000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-4009000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22321000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22321000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22321000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,105237000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,105237000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,105100000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:13:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,25374000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:13:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,25374000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:13:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,533000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:13:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,533000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:13:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24841000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:13:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14857000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:13:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,47696000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:13:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,62553000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:13:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-37712000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:13:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5113000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:13:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5113000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:13:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-42825000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:13:04+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1005000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:13:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-41820000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:13:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-41820000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:13:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-41820000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:13:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,104600000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:13:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.4
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:13:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,104600000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:13:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.4
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:13:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,105668000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q1,2018-01-01,2018-03-31,2019-05-01 16:13:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.4
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:53:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13798000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:53:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13798000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:53:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,838000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:53:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,838000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:53:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12960000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:53:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16755000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:53:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26477000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:53:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43232000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:53:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-30272000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:53:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5187000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:53:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5187000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:53:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-35459000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:53:25+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,910000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:53:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34549000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:53:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34549000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:53:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-34549000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:53:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,104700000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:53:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.33
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:53:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,104700000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:53:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.33
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:53:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,105848000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q2,2018-04-01,2018-06-30,2019-08-01 16:53:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.33
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:06:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6966000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:06:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6966000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:06:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,551000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:06:17+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,551000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:06:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6415000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:06:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15579000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:06:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13763000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:06:17+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:06:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29342000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:06:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22927000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:06:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5252000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:06:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,783000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:06:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4469000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:06:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-27396000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:06:17+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,0.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:06:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27396000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:06:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27396000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:06:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27396000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:06:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,105881000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:06:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.26
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:06:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,105881000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:06:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.26
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:06:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,105400000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:06:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17071000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17071000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,569000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,569000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16502000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16563000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12307000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28870000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12368000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5225000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2725000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2500000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14868000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-1915000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16783000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16783000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16783000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,105830000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,105830000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,105700000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 16:20:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9216000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 16:20:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9216000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 16:20:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,553000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 16:20:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,553000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 16:20:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8663000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 16:20:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14110000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 16:20:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12022000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 16:20:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26132000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 16:20:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17469000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 16:20:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5117000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 16:20:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,789000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 16:20:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4328000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 16:20:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21797000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 16:20:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21797000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 16:20:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21797000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 16:20:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21797000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 16:20:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,106054000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 16:20:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.21
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 16:20:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,103800000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 16:20:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 16:20:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,103800000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 16:20:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.21
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:53:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9682000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:53:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9682000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:53:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1327000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:53:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1327000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:53:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8355000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:53:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14263000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:53:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12637000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:53:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26900000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:53:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18545000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:53:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5164000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:53:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5164000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:53:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23709000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:53:25+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,691000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:53:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23018000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:53:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23018000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:53:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23018000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:53:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,104600000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:53:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:53:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,104600000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:53:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:53:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,106272000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q2,2019-04-01,2019-06-30,2019-08-01 16:53:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:06:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,294448000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:06:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,294448000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:06:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,577000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:06:17+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,577000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:06:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,293871000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:06:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13898000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:06:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26659000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:06:17+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,28638000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:06:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,69195000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:06:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,224676000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:06:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5204000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:06:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,600000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:06:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4604000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:06:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,220072000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:06:17+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,6014000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:06:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,226086000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:06:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,226086000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:06:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,226086000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:06:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,106272000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:06:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.13
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:06:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,116640000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:06:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.95
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:06:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,106100000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:06:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.13
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8727000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8727000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,774000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,774000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7953000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14564000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,40606000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,55170000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-47217000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5191000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1961000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3230000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-50447000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-6014000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-6705000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-51138000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-51138000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-51138000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,106218000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.47
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,116747000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,105800000.0
Lexicon Pharmaceuticals Inc,LXRX,,0001062822,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.47
